August 2, 2007Movement Disorders
The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study
Authors
Discussion
Loading...
Member takes
Implication
Multicenter cross-sectional study demonstrates the reliability and validity of a novel non-motor symptoms scale in Parkinson's disease, suggesting strong utility for clinical monitoring.
Key Points
- To evaluate the metric properties, reliability, and validity of a newly developed 30-item non-motor symptoms scale (NMSS) across various stages of Parkinson's disease.
- Conducted an international pilot validation study enrolling 242 patients with Parkinson's disease across clinical centers in Europe, the United States, and Japan (mean age 67.2 ± 11 years, 57.3% male, disease duration 6.4 ± 6 years).
- Assessed data completeness, floor and ceiling effects, factor structure, internal consistency, test-retest reproducibility, and construct validity against the NMSQuest and PDQ-8 instruments.
- The mean NMSS score was 56.5 ± 40.7 (range: 0–243) with 99.2% complete data and no floor or ceiling effects for total score; factor analysis confirmed the nine-domain structure, accounting for 63% of the variance.
- Multitrait scaling success exceeded 95% for eight domains, test-retest reproducibility showed an intraclass correlation coefficient (ICC) > 0.80 for eight domains (cardiovascular ICC = 0.45), and NMSS scores strongly correlated with both NMSQuest and PDQ-8 (both Spearman r = 0.70).
Cite This Study
Chaudhuri et al. (2007) studied this question.